Publication | Open Access

Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer’s disease

Neurodegenerative DiseasesAlzheimer's DiseaseNeurobiology Of DiseaseCandidate DrugNeuroepidemiologyMedicineNeurochemical BiomarkersAlzheimer ’NeurologyNeuroscienceNeurodegenerationAging-associated DiseasePharmacologySocial Sciences